Brain Cancer

"There are many young scientists in a similar position that could greatly benefit from the support at the early stages in their career."


Justin Lathia, PH.D.
Cleveland Clinic

Molecular Studies

"The Ohio Cancer Research award was instrumental in getting my laboratory off the ground as a new faculty member."


Denis Guttridge, PH.D.
The Ohio State University

Breast Cancer

"For many in my position such achevements would not be possible without these early investments and I thank you for supporting OCR and enabling the cutting edge scientific projects of Ohio's talented young researchers."

Matthew Summers, PH.D.
Cleveland Clinic,
The Ohio State University

Gene Mutation

"The Ohio Cancer Research grant really sowed the seed of success for me to acquire $1.8 million federal funding since I joined the University of Toledo."


Song-Tao Liu, PH.D.
University of Toledo

Lung Cancer

"Research matters because lung cancer is poorly understood and current therapies are insufficient to save the lives of patients."

Anne Strohecker, PH.D.
The Ohio State University

Funded with the support of Celeste and David Loewendick

Breast Cancer

"The lifetime risk of developing invasive breast cancer is 1 in 8 in women in the United States and 20% of the breast cancer patients die. We are exploring strategies to reduce breast cancer deaths in the clinic."


Huiping Liu, M.D., PH.D.
Case Western Reserve University

Cancer Therapy

"Metastasis, the spread of cancer from the original tumor to other sites in the body, is the main cause of death in most cancer patients. We believe our research will contribute to the identification of new therapeutic targets to reduce cancer cell invasion and metastasis."


Jennifer Leight, PH.D.
The Ohio State University

Ohio Cancer Research’s scientific investigators are exploring innovative areas of cancer research in the genetic causes and preventions of cancer, skin cancer, stomach cancer, prostate cancer, colon cancer, liver cancer, kidney cancer, breast cancer, leukemia, vaccine studies, DNA studies, and new therapeutic strategies.

Projects are selected by a Scientific Review Committee with the help of out- of-state reviewers from across the country and the world.

The Scientific Review Committee is comprised of doctors and scientists around the state. Committee Chair Susan Cole, PhD, The Ohio State University, heads this distinguished panel of researchers and cancer experts in 2017:

SCIENTIFIC REVIEW COMMITTEE

Susan Cole, PhD

Professor, Cancer and Cell Biology
Molecular Genetics, The Ohio State University

Ivana de la Serna, PhD

Associate Professor
Biochemistry & Cancer Biology, University of Toledo

Sohaib Khan, PhD

Associate Professor
Professor of Cell Biology, University of Cincinnati College of Medicine

Justin Lathia, PhD

Associate Staff
Cellular & Molecular Medicine, Cleveland Clinic

Ricky Leung, PhD

Research Assistant Professor
Environmental Health, University of Cincinnati

Deborah Paris, PhD

Professor Emeritus
The Ohio State University

John Pink, PhD

Assistant Professor
General Medical Sciences Oncology, Case Western Reserve University

Dawn Wooley, PhD

Associate Professor, Neuroscience Cell
Biology & Physiology, Wright State University

Ana Luisa Kadekaro, PhD

Assistant Professor
Dermatology, University of Cincinnati

Tom Cunningham, PhD

Assistant Professor
Cancer Biology, University of Cincinnati